Schroder Investment Management Group’s Apellis Pharmaceuticals APLS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $8.41M | Buy |
485,615
+232,506
| +92% | +$4.02M | 0.01% | 667 |
|
|
2025
Q1 | $6.14M | Buy |
253,109
+33,726
| +15% | +$819K | 0.01% | 722 |
|
|
2024
Q4 | $7M | Hold |
219,383
| – | – | 0.01% | 714 |
|
|
2024
Q3 | $6.47M | Buy |
219,383
+50,980
| +30% | +$1.5M | 0.01% | 744 |
|
|
2024
Q2 | $6.46M | Buy |
168,403
+128,000
| +317% | +$4.91M | 0.01% | 727 |
|
|
2024
Q1 | $2.37M | Buy |
40,403
+16,721
| +71% | +$983K | ﹤0.01% | 899 |
|
|
2023
Q4 | $1.42M | Buy |
+23,682
| New | +$1.42M | ﹤0.01% | 961 |
|